GST to benefit pharma industry, but pricing remains a concern2 min read 05 Aug 2016, 03:51 PM IST
GST is expected to be a win-win situation for drug makers as it will not only simplify tax structure but also create a level-playing field for pharmaceutical companies
Hyderabad: The goods and services tax (GST), India’s biggest indirect tax reform, is expected to be beneficial for Indian drug makers in the medium to long run as it aims to simplify tax structure and bring operational efficiency. However, concerns about drug prices, exemptions and compliance remain.
Select your Category